Join to View Full Profile
8435 Wurzbach RdSte 305San Antonio, TX 78229
Phone+1 210-450-9800
Fax+1 210-450-4935
Dr. Habib is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2017- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2011 - 2014
Texas Tech University Health Sciences Center School of MedicineClass of 2011
Certifications & Licensure
TX State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Economic Evaluation of a Novel Lung Cancer Diagnostic in a Population of Patients with a Positive Low-Dose Computed Tomography Result.Michael J Morris, Sheila A Habib, Maggie L Do Valle, John E Schneider
Journal of Health Economics and Outcomes Research. 2024-01-01 - 8 citationsDetection of early-stage lung cancer in sputum using automated flow cytometry and machine learning.Madeleine E Lemieux, Xavier T Reveles, Jennifer Rebeles, Lydia H Bederka, Patricia R Araujo
Respiratory Research. 2023-01-21 - 3 citationsRare but Fatal Pasteurella multocida Infective Endocarditis: A Case Report and Literature Review.Mohamed Mahmoud, Khadija El Kortbi, Mohamed I Abdalla, Sheila Habib
Cureus. 2022-03-01
Press Mentions
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer RecurrenceMarch 20th, 2025- Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung CancerMarch 13th, 2025
- bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® LungJanuary 13th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
